Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Single Antiplatelet Therapy With a Potent P2Y12 Inhibitor After Intravascular Ultrasound-Guided PCI in Patients With Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial

NCT07684742 is registered in ClinicalTrials.gov with Gyeongsang National University Hospital as lead sponsor.

NCT NCT07684742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07684742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Single Antiplatelet Therapy With a Potent P2Y12 Inhibitor After Intravascular Ultrasound-Guided PCI in Patients With Acute Coronary Syndrome: A Multicenter Randomized Controlled Trial
Lead sponsor
Gyeongsang National University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
July 1, 2032
Enrollment
1,900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, nstemi, stemi, unstable angina